Besides, analysis using Human Protein Atlas database also revealed that EZH2 and NSD2 were predominantly located in the cell nucleus, and the medium/high expression rates of EZH2 and NSD2 in BC were 83.33% (10/12 cases) and 100% (10/10 cases), respectively (Figure 1C). This evidence concerns the gene EZH2 and breast cancer.